Patient Square Capital Closes $3.9 Billion Inaugural Fund

Patient Square Capital, a Menlo Park, CA-based health care investment firm, closed its inaugural fund, at approximately $3.9 billion.

LPs include a diverse and global set of institutional investors, including leading sovereign wealth funds, pension funds, endowments, foundations, family offices, health systems, consultants, private wealth platforms, and insurance companies.  

The firm invests broadly across the health care industry, including development-stage therapeutics; commercial-stage pharmaceuticals; medical devices, diagnostics, and life science tools; health care providers; and technology-enabled and other services. Portfolio companies include Access Telecare, Apollo Therapeutics, Eargo, Enavate Sciences, Hanger Inc., Kriya Therapeutics, Radius Health, Resolve Biosciences, and Summit BHC.

Patient Square Capital is a dedicated health care investment firm that partners with management teams whose products, services and technologies improve health. The firm utilizes industry expertise, a broad network of relationships and a partnership approach to make investments in companies grow and thrive.

Patient Square’s total assets under management (“AUM”) is approximately $5.9 billion, including significant co-investment commitments from leading institutional investors.

FinSMEs

02/02/2023

No Byline Policy

Editorial Guidelines

Corrections Policy

Source